Akèy › Maladi Fabry › Virginia › Arlington
Etid klinik pou Maladi Fabry nan Arlington, VA
6 etid pou Maladi Fabry ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
Ap rekriteFaz 1/2
- Lysosomal & Rare Disorders Research and Treatment Center, Inc, Fairfax · 11 mi lwen
A Study of Patients With Fabry Disease (US Specific)
Ap rekriteEtid obsèvasyon
- Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax · 11 mi lwen
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Ap rekriteFaz 3
- Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax · 11 mi lwen
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Ap rekriteFaz 2/3
- Lysosomal and Rare Disorders Research and Treatment Center Inc, Fairfax · 11 mi lwen
Fabry Disease Registry & Pregnancy Sub-registry
Ap rekriteEtid obsèvasyon
- O & O Alpan- Site Number : 840025, Fairfax · 11 mi lwen
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Ap rekriteEtid obsèvasyon
- Lysosomal & Rare Disorder Research & Treatment Center (LRDRTC), Fairfax · 11 mi lwen
Etid Maladi Fabry nan lòt vil
- Atlanta, GA6 etid
- Pittsburgh, PA4 etid
- Birmingham, AL4 etid
- Cincinnati, OH4 etid
- Minneapolis, MN4 etid
- Salt Lake City, UT3 etid
- Chicago, IL3 etid
- Cedar Rapids, IA3 etid
- New York City, NY3 etid
Lòt etid nan Arlington
- Kansè Poumon ki pa ti selil104 etid
- Kansè Metastatik53 etid
- Kansè kolorektal52 etid
- Kansè (tout kalite)48 etid
- Kansè nan tete46 etid
- Kansè ovè46 etid
- Kansè poumon41 etid
- Kansè Endomèt39 etid
- Kansè pankreyas33 etid
- Karsinòm selil skuamèz tèt ak kou26 etid
- Kansè poumon selil ti23 etid
- Kansè tete negatif triple20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.